- Home
- SXTP
as of 08-27-2026 4:00pm EST
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.
| Founded: | 2010 | Country: | United States |
| Employees: | N/A | City: | WASHINGTON |
| Market Cap: | 3.0M | IPO Year: | 2023 |
| Target Price: | $14.10 | AVG Volume (30 days): | 78.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.10 | EPS Growth: | 36.77 |
| 52 Week Low/High: | $0.34 - $8.62 | Next Earning Date: | 05-15-2026 |
| Revenue: | $1,005,471 | Revenue Growth: | 65.49% |
| Revenue Growth (this year): | 33.92% | Revenue Growth (next year): | 51.35% |
| P/E Ratio: | -0.51 | Index: | N/A |
| Free Cash Flow: | -6988903.0 | FCF Growth: | N/A |
Compare SXTP vs Leading Stocks
See how SXTP stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "SXTP 60 Degrees Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.